These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35283491)

  • 1. HLA-Cw6 Status and Treatment Responses Between Psoriasis Patients.
    Temel B; Adisen E; Gonen S
    Indian J Dermatol; 2021; 66(6):632-637. PubMed ID: 35283491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
    Costanzo A; Bianchi L; Flori ML; Malara G; Stingeni L; Bartezaghi M; Carraro L; Castellino G;
    Br J Dermatol; 2018 Nov; 179(5):1072-1080. PubMed ID: 29704432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab.
    Talamonti M; Botti E; Galluzzo M; Teoli M; Spallone G; Bavetta M; Chimenti S; Costanzo A
    Br J Dermatol; 2013 Aug; 169(2):458-63. PubMed ID: 23521149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis.
    Chiu HY; Wang TS; Chan CC; Cheng YP; Lin SJ; Tsai TF
    Br J Dermatol; 2014 Nov; 171(5):1181-8. PubMed ID: 24734995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab.
    De Keyser E; Busard CI; Lanssens S; Meuleman L; Hutten BA; Costanzo A; van den Reek JM; Zweegers J; Lambert J; Spuls PI
    Ther Drug Monit; 2019 Oct; 41(5):634-639. PubMed ID: 31107404
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Morelli M; Galluzzo M; Madonna S; Scarponi C; Scaglione GL; Galluccio T; Andreani M; Pallotta S; Girolomoni G; Bianchi L; Talamonti M; Albanesi C
    Expert Opin Biol Ther; 2021 Feb; 21(2):259-270. PubMed ID: 33297781
    [No Abstract]   [Full Text] [Related]  

  • 7. Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis.
    Anzengruber F; Ghosh A; Maul JT; Drach M; Navarini AA
    Psoriasis (Auckl); 2017; 8():7-11. PubMed ID: 29721444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.
    Talamonti M; Galluzzo M; Zangrilli A; Papoutsaki M; Egan CG; Bavetta M; Tambone S; Fargnoli MC; Bianchi L
    Mol Diagn Ther; 2017 Jun; 21(3):295-301. PubMed ID: 28130758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-Cw6 and psoriasis.
    Chen L; Tsai TF
    Br J Dermatol; 2018 Apr; 178(4):854-862. PubMed ID: 29072309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of HLA-Cw6 Positivity with Clinical Characteristics and Treatment Efficacy in Korean Patients with Psoriasis.
    Kim SM; Lee H; Lee ES
    Ann Dermatol; 2022 Aug; 34(4):253-260. PubMed ID: 35948327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment.
    West J; Ogston S; Berg J; Palmer C; Fleming C; Kumar V; Foerster J
    Clin Exp Dermatol; 2017 Aug; 42(6):651-655. PubMed ID: 28512993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA-C*06:02 Status With Differential Response to Ustekinumab in Patients With Psoriasis: A Systematic Review and Meta-analysis.
    van Vugt LJ; van den Reek JMPA; Hannink G; Coenen MJH; de Jong EMGJ
    JAMA Dermatol; 2019 Jun; 155(6):708-715. PubMed ID: 30994858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile of childhood-onset psoriasis and prevalence of HLA-Cw6: a hospital-based study from India.
    Sathishkumar D; George R; Daniel D; Peter JV
    Postgrad Med J; 2015 Jun; 91(1076):309-14. PubMed ID: 25947201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients.
    Batalla A; Coto E; González-Fernández D; González-Lara L; Gómez J; Santos-Juanes J; Queiro R; Coto-Segura P
    Pharmacogenet Genomics; 2015 Jun; 25(6):313-6. PubMed ID: 25794162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis.
    Coto-Segura P; González-Lara L; Batalla A; Eiris N; Queiro R; Coto E
    Mol Diagn Ther; 2019 Oct; 23(5):627-633. PubMed ID: 31267486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis.
    Burlando M; Russo R; Clapasson A; Carmisciano L; Stecca A; Cozzani E; Parodi A
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32998429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features.
    Gudjónsson JE; Kárason A; Antonsdóttir AA; Rúnarsdóttir EH; Gulcher JR; Stefánsson K; Valdimarsson H
    J Invest Dermatol; 2002 Feb; 118(2):362-5. PubMed ID: 11841557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis.
    Queiro R; Torre JC; González S; López-Larrea C; Tinturé T; López-Lagunas I
    J Rheumatol; 2003 Mar; 30(3):505-7. PubMed ID: 12610809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China.
    Jin Y; Yang S; Zhang F; Kong Y; Xiao F; Hou Y; Fan X; Zhang X
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):132-7. PubMed ID: 18702622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.